60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
0.9000
-0.0300 (-3.23%)
At close: Sep 11, 2026, 4:00 PM EDT
0.9006
+0.0006 (0.07%)
After-hours: Sep 11, 2026, 7:48 PM EDT
60 Degrees Pharmaceuticals Employees
60 Degrees Pharmaceuticals had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$404,977
Profits / Employee
-$2,874,812
Market Cap
3.17M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PMGC Holdings | 34 |
| Aptevo Therapeutics | 33 |
| Calidi Biotherapeutics | 29 |
| GeoVax Labs | 19 |
| BioRestorative Therapies | 14 |
| Genprex | 13 |
| Artelo Biosciences | 7 |
| Silo Pharma | 3 |
SXTP News
- 1 day ago - 60 Degrees Pharmaceuticals Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 9 days ago - 60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 4 weeks ago - 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results - GlobeNewsWire
- 4 weeks ago - 60 Degrees Pharmaceuticals Registration statement: Registration filing - Filings
- 4 weeks ago - 60 Degrees Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 4 weeks ago - 60 Degrees Pharmaceuticals Earnings release: Q2 2026 - Filings
- 6 weeks ago - 60 Degrees Pharmaceuticals to sell shares and warrants in private placement - TheFly
- 6 weeks ago - 60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire